INmune Bio Inc (INMB)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -122.566 | -8.81 | -69.544 | -36.708 | -37.156 | -43.158 | -30.042 | -43.24 |
Return on Equity (%) | 371.812 | -9.256 | -71.816 | -38.247 | -38.802 | -51.001 | -38.907 | -61.59 |
Return on Invested Capital (%) | 304.698 | -10.927 | -71.816 | -38.635 | -39.212 | -43.728 | -31.592 | -55.224 |
Operating Margin (%) | N/A | N/A | N/A | N/A | -109990.909 | -16762.431 | -7299.198 | -19360 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | -109990.909 | -16762.431 | -7299.198 | -19360 |
Book Value Per Share | -0.029 | 0.191 | 0.003 | 0.659 | 1.65 | 3.571 | 2.429 | 1.2 |
Earnings Per Share | -0.055 | -0.1 | -1.427 | -0.713 | -0.897 | -1.7 | -1.521 | -1.665 |
Cash Per Share | 0.028 | 0.165 | 0.021 | 0.65 | 1.629 | 4.193 | 2.906 | 1.989 |
Working Capital Per Share | -0.029 | 0.191 | 0.003 | 0.656 | 1.647 | 4.385 | 2.995 | 1.192 |
Operating Profit Per Share | N/A | N/A | N/A | 0.143 | 0.001 | 0.01 | 0.021 | 0.009 |
EBIT Per Share | -0.055 | -0.1 | -1.427 | -0.713 | -0.897 | -1.7 | -1.521 | -1.665 |
EBITDA Per Share | -0.055 | -0.1 | -1.427 | -0.713 | -0.897 | -1.7 | -1.521 | -1.665 |
Free Cash Flow Per Share | -0.055 | -0.088 | -1.427 | -0.713 | -0.897 | -0.86 | -1.521 | -1.665 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.07M | 8.32M | 8.72M | 10.77M | 13.48M | 17.84M | 17.95M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 17.95M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -17200 | N/A | N/A | N/A | -78750 | N/A | N/A |
Net Profit Margin (%) | N/A | -17200 | N/A | N/A | N/A | -78750 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 98M |
Price to Earnings Ratio | -3.24 |
Price to Sales Ratio | 625.71 |
Price to Cash Ratio | 2.71 |
Price to Book Ratio | 2.55 |
Dividend Yield | - |
Shares Outstanding | 22.17M |
Average Volume (1 week) | 256.13k |
Average Volume (1 Month) | 203.2k |
52 Week Change | -57.07% |
52 Week High | 14.74 |
52 Week Low | 4.36 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.